JP2016516400A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016516400A5 JP2016516400A5 JP2015561931A JP2015561931A JP2016516400A5 JP 2016516400 A5 JP2016516400 A5 JP 2016516400A5 JP 2015561931 A JP2015561931 A JP 2015561931A JP 2015561931 A JP2015561931 A JP 2015561931A JP 2016516400 A5 JP2016516400 A5 JP 2016516400A5
- Authority
- JP
- Japan
- Prior art keywords
- monoclonal antibody
- antigen
- binding fragment
- protein
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310082338 | 2013-03-15 | ||
| CN201310082338.1 | 2013-03-15 | ||
| PCT/CN2014/073505 WO2014139476A1 (zh) | 2013-03-15 | 2014-03-17 | Rsv融合蛋白的表位以及识别其的抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016516400A JP2016516400A (ja) | 2016-06-09 |
| JP2016516400A5 true JP2016516400A5 (enExample) | 2017-03-30 |
| JP6462599B2 JP6462599B2 (ja) | 2019-01-30 |
Family
ID=51535878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015561931A Active JP6462599B2 (ja) | 2013-03-15 | 2014-03-17 | Ｒｓｖ融合タンパク質のエピトープ及びそのエピトープを認識する抗体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9856313B2 (enExample) |
| EP (1) | EP2975052B1 (enExample) |
| JP (1) | JP6462599B2 (enExample) |
| CN (1) | CN105722856B (enExample) |
| AU (1) | AU2014231357B2 (enExample) |
| CA (1) | CA2906960C (enExample) |
| WO (1) | WO2014139476A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105473604B (zh) | 2013-03-13 | 2021-01-22 | 美国政府(由卫生和人类服务部的部长所代表) | 融合前rsv f蛋白和其用途 |
| US9738689B2 (en) | 2013-03-13 | 2017-08-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Prefusion RSV F proteins and their use |
| US9630994B2 (en) | 2014-11-03 | 2017-04-25 | University Of Washington | Polypeptides for use in self-assembling protein nanostructures |
| CN106496324B (zh) * | 2015-11-30 | 2020-01-14 | 天津昊免生物技术有限公司 | 一种抗呼吸道合胞病毒的全人源抗体 |
| KR20220041966A (ko) * | 2016-04-05 | 2022-04-01 | 얀센 백신스 앤드 프리벤션 비.브이. | 안정화된 용해성 융합-전 rsv f 단백질 |
| SG11201903287PA (en) * | 2016-10-21 | 2019-05-30 | Adimab Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| CN110121509B (zh) * | 2016-10-26 | 2024-05-07 | 西达-赛奈医疗中心 | 中和抗tl1a单克隆抗体 |
| EP3554545A4 (en) | 2016-12-19 | 2020-08-12 | Vanderbilt University | ANTIBODIES DIRECTED AGAINST HUMAN RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION PROTEIN CONFORMATION AND THEIR USE METHODS |
| CN108265079A (zh) * | 2017-01-02 | 2018-07-10 | 刘昕 | 一种新型呼吸道合胞体病毒pre-F融合蛋白载体的制备方法 |
| WO2018130072A1 (zh) * | 2017-01-12 | 2018-07-19 | 厦门大学 | 稳定呼吸道合胞病毒融合蛋白的方法 |
| CN110603262A (zh) | 2017-04-04 | 2019-12-20 | 华盛顿大学 | 显示副粘病毒和/或肺炎病毒f蛋白的自组装蛋白纳米结构及其用途 |
| AU2019228551B2 (en) | 2018-02-28 | 2025-07-24 | University Of Washington | Self-assembling nanostructure vaccines |
| CN110684747B (zh) * | 2018-07-06 | 2024-05-24 | 厦门大学 | 灭活及保存呼吸道合胞病毒的方法 |
| CN111057718A (zh) * | 2018-10-17 | 2020-04-24 | 南京大学 | 一种稳定表达绿色荧光蛋白的egfp-sp2/0细胞株及其构建方法 |
| WO2020175660A1 (ja) * | 2019-02-28 | 2020-09-03 | Ｋｍバイオロジクス株式会社 | Ｒｓｖ ｆ／ｇキメラワクチン |
| WO2021242294A1 (en) * | 2020-05-28 | 2021-12-02 | Sotira Covid, Llc | Peptides for covid-19 prevention and treatment |
| WO2022268120A1 (en) * | 2021-06-22 | 2022-12-29 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. | Anti-rsv antibodies and uses thereof |
| EP4446339A4 (en) * | 2021-12-06 | 2026-01-14 | Univ Xiamen | ANTIBODIES TO RECOGNIZE A PRE-F PROTEIN OF RSV AND ITS USAGE |
| CN116478296B (zh) * | 2022-10-17 | 2024-02-23 | 厦门大学 | 截短的呼吸道合胞病毒f蛋白及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5811524A (en) | 1995-06-07 | 1998-09-22 | Idec Pharmaceuticals Corporation | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| US7771951B2 (en) | 2001-12-03 | 2010-08-10 | Amgen Fremont Inc. | Antibody categorization based on binding characteristics |
| EP1997830A1 (en) * | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
| BR112012008173B1 (pt) | 2009-10-06 | 2021-12-07 | Medimmune Ltd | Anticorpo monoclonal humano recombinante, sintético ou isolado ou uma parte funcional do mesmo que se liga especificamente à proteína f do vírus sincicial respiratório, sequência de ácido nucleico isolada ou um equivalente funcional da mesma, vetor, combinação, composição farmacêutica, usos dos mesmos e método para produzir um anticorpo ou parte funcional do mesmo |
| US8568726B2 (en) | 2009-10-06 | 2013-10-29 | Medimmune Limited | RSV specific binding molecule |
| TWI627964B (zh) * | 2010-07-09 | 2018-07-01 | 傑森疫苗防護公司 | 抗-人類呼吸道融合性病毒（ｒｓｖ）抗體及其使用方法 |
| CN102210860B (zh) * | 2011-05-31 | 2012-11-21 | 昆明理工大学 | 一种结核分枝杆菌tb10．4-f1融合蛋白疫苗及制备方法 |
-
2014
- 2014-03-17 CA CA2906960A patent/CA2906960C/en active Active
- 2014-03-17 JP JP2015561931A patent/JP6462599B2/ja active Active
- 2014-03-17 CN CN201480013927.7A patent/CN105722856B/zh active Active
- 2014-03-17 WO PCT/CN2014/073505 patent/WO2014139476A1/zh not_active Ceased
- 2014-03-17 US US14/777,275 patent/US9856313B2/en active Active
- 2014-03-17 AU AU2014231357A patent/AU2014231357B2/en active Active
- 2014-03-17 EP EP14765573.2A patent/EP2975052B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016516400A5 (enExample) | ||
| JP2015511817A5 (enExample) | ||
| WO2022271884A2 (en) | Methods and compositions relating to covid antibody epitopes | |
| JP2018521638A5 (enExample) | ||
| JP2020535799A5 (enExample) | ||
| IL273196B2 (en) | Claudin6 antibodies and methods of treating cancer | |
| JP2021500916A5 (enExample) | ||
| JP2020536488A5 (enExample) | ||
| JP2019054802A5 (enExample) | ||
| JP2013538057A5 (enExample) | ||
| JP2014526898A5 (enExample) | ||
| RU2016129274A (ru) | Канинизированные мышиные антитела к человеческому pd-1 | |
| JP2013198490A5 (enExample) | ||
| JP2020522261A5 (enExample) | ||
| JP2018504105A5 (enExample) | ||
| RU2017134495A (ru) | Антитела к альфа-рецептору собачьего интерлейкина-4 | |
| JP2009225799A5 (enExample) | ||
| US12325739B2 (en) | Bispecific SARS-CoV-2 antibodies and methods of use | |
| JP2013506428A5 (enExample) | ||
| JP2017149720A5 (enExample) | ||
| RU2017114341A (ru) | Антитела к pd-l1, связывающие pd-l1 собаки | |
| JP2014511179A5 (enExample) | ||
| JP2018516853A5 (enExample) | ||
| JP2011173884A5 (enExample) | ||
| JP2012010714A5 (enExample) |